Skip to content

Long-Term Follow-up of AvenCell-Sponsored CAR-T Cell Clinical Trials

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521717-67-00
Acronym
AVC-PERSIST
Enrollment
10
Registered
2025-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myeloid leukemia

Interventions

None listed

Sponsors

Avencell Therapeutics Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026